Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Redeemable Noncontrolling Interests and Equity

v3.21.1
Consolidated Statements of Redeemable Noncontrolling Interests and Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Redeemable Noncontrolling Interests
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Total Stockholders' Equity
Noncontrolling Interests
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Total Stockholders' Equity
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Beginning balance (in shares)     118,451                
Beginning balance at Dec. 31, 2019   $ 306,565                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Beginning balance (in shares)     120,123                
Beginning balance at Dec. 31, 2019 $ 1,331,432   $ 12 $ 766,006 $ (52,753) $ 251,466 $ 964,731 $ 366,701 $ (1,228) $ (1,228) $ (1,228)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Exercise of stock options (in shares)     1,009                
Exercise of stock options 5,949     5,949     5,949        
Issuance of restricted stock units (in shares)     663                
Issuance of restricted stock units (3,530)   $ 0 (3,530)     (3,530)        
Stock-based compensation 6,808     6,808     6,808        
Contributions from noncontrolling interests and redeemable noncontrolling interests 20,000 150,904           20,000      
Distributions to noncontrolling interests and redeemable noncontrolling interests (13,612) (7,084)           (13,612)      
Net (loss) income (74,857) (34,692)       (27,959) (27,959) (46,898)      
Other comprehensive income, net of taxes (72,298)       (72,298)   (72,298)        
Ending balance at Mar. 31, 2020   415,693                  
Ending balance (in shares) at Mar. 31, 2020     120,123                
Ending balance at Mar. 31, 2020 1,198,664   $ 12 775,233 (125,051) 222,279 872,473 326,191      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Beginning balance (in shares)     120,123                
Beginning balance (in shares)     201,406                
Beginning balance at Dec. 31, 2020 560,461 560,461                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Beginning balance (in shares)     203,562                
Beginning balance at Dec. 31, 2020 $ 6,728,910   $ 20 6,107,802 (106,755) 76,844 6,077,911 650,999 $ (1,731)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Exercise of stock options (in shares) 898   898                
Exercise of stock options $ 8,541     8,541     8,541        
Issuance of restricted stock units (in shares)     1,258                
Issuance of restricted stock units 0   $ 0       0        
Stock-based compensation 80,632     80,632     80,632        
Contributions from noncontrolling interests and redeemable noncontrolling interests 271,384 (23,691)           271,384      
Distributions to noncontrolling interests and redeemable noncontrolling interests (30,943) (16,069)           (30,943)      
Net (loss) income (224,487) 20,165       (23,789) (23,789) (200,698)      
Capped call transaction (28,000)     (28,000)     (28,000)        
Acquisition of noncontrolling interests 272 (4,572)   272     272        
Other comprehensive income, net of taxes 49,993       49,993   49,993        
Ending balance at Mar. 31, 2021 536,294 $ 536,294                  
Ending balance (in shares) at Mar. 31, 2021     203,562                
Ending balance at Mar. 31, 2021 $ 6,856,302   $ 20 $ 6,169,247 $ (56,762) $ 53,055 $ 6,165,560 $ 690,742      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Beginning balance (in shares)     203,562